Xiamen Amoytop Biotech Co., Ltd. (688278.SS)
CNY 71.53
(1.26%)
CNY 71.53
(1.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.1 Billion | 1.52 Billion | 1.13 Billion | 793.93 Million | 729.66 Million | 448.28 Million |
| Cost of Revenue | 143.15 Million | 169.23 Million | 125.13 Million | 83.64 Million | 79.97 Million | 55.93 Million |
| Gross Profit | 1.95 Billion | 1.35 Billion | 1 Billion | 710.28 Million | 649.69 Million | 392.34 Million |
| Operating Expenses | 1.27 Billion | 959.54 Million | 767.35 Million | 556.65 Million | 522.86 Million | 350.53 Million |
| Selling, General and Administrative Expenses | 1.05 Billion | 736.46 Million | 620.43 Million | 446.84 Million | 436.28 Million | 278.86 Million |
| Research and Development Expenses | 221.35 Million | 149.83 Million | 81.5 Million | 76.67 Million | 53.4 Million | 40.6 Million |
| Other Expenses | -2.72 Million | 73.24 Million | 65.4 Million | 33.12 Million | 33.16 Million | -25.93 Million |
| Cost and Expenses | 1.41 Billion | 1.12 Billion | 892.48 Million | 640.3 Million | 602.83 Million | 406.47 Million |
| Operating Income | 680.72 Million | 406.92 Million | 248.52 Million | 158.14 Million | 116.06 Million | 34.71 Million |
| Interest Expense | 784.06 Thousand | 620.72 Thousand | 1.07 Million | 2.46 Million | 6.3 Million | 7.22 Million |
| Income Tax Expense | 85.2 Million | 68.9 Million | 34.08 Million | 22.49 Million | 26.71 Million | -1.72 Million |
| Earnings before Tax | 640.65 Million | 355.92 Million | 215.28 Million | 139.06 Million | 91.01 Million | 14.27 Million |
| Net Income | 555.44 Million | 287.01 Million | 181.2 Million | 116.56 Million | 64.29 Million | 16 Million |
| Earnings Per Share Basic | 1.37 | 0.71 | 0.45 | 0.29 | 0.16 | 0.04 |
| Earnings Per Share Diluted | 1.37 | 0.71 | 0.45 | 0.29 | 0.16 | 0.04 |
| Weighted Average Shares Outstanding | 405.43 Million | 406.8 Million | 406.8 Million | 406.8 Million | 406.8 Million | 400.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 405.43 Million | 406.8 Million | 406.8 Million | 406.8 Million | 406.8 Million | 400.07 Million |
| Gross Margin | 0.93 | 0.89 | 0.89 | 0.89 | 0.89 | 0.88 |
| EBIT Margin | 0.34 | 0.26 | 0.23 | 0.22 | 0.19 | 0.13 |
| Profit Margin | 0.26 | 0.19 | 0.16 | 0.15 | 0.09 | 0.04 |
| EBITDA | 709.65 Million | 404.62 Million | 260.9 Million | 179.69 Million | 135.09 Million | 68.12 Million |
| Earnings Before Tax Margin | 0.32 | 0.27 | 0.22 | 0.20 | 0.16 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 764.89 Million | 641.17 Million | 545.3 Million | 2.1 Billion | 640.53 Million | 556.21 Million |
| Cost of Revenue | 50.96 Million | 44.39 Million | 37.76 Million | 140.05 Million | 46.43 Million | 29.79 Million |
| Gross Profit | 713.93 Million | 596.77 Million | 507.53 Million | 1.96 Billion | 594.09 Million | 526.41 Million |
| Operating Expenses | 427.68 Million | 390.25 Million | 339.34 Million | 1.42 Billion | 1.42 Billion | 317.4 Million |
| Selling, General and Administrative Expenses | 613.24 Million | 321.12 Million | 296.3 Million | - | 304.3 Million | 320.3 Million |
| Research and Development Expenses | 79.43 Million | 68.89 Million | 43.57 Million | - | 87.11 Million | 65.65 Million |
| Other Expenses | -264.98 Million | -241.18 Thousand | -13.14 Million | -1.42 Billion | -1.42 Billion | -11.03 Million |
| Cost and Expenses | 478.64 Million | 434.64 Million | 377.1 Million | 1.42 Billion | 1.42 Billion | 347.2 Million |
| Operating Income | 287.7 Million | 206.52 Million | 170.51 Million | 679.93 Million | -780.48 Million | 212.04 Million |
| Interest Expense | 127.94 Thousand | 115.3 Thousand | 114.11 Thousand | 506.17 Thousand | 134.81 Thousand | 121.72 Thousand |
| Income Tax Expense | 30.34 Million | 32.69 Million | 28.56 Million | 85.2 Million | 6.43 Million | 34.28 Million |
| Earnings before Tax | 280.15 Million | 208.22 Million | 157.36 Million | 639.86 Million | 192.19 Million | 201.01 Million |
| Net Income | 249.8 Million | 175.53 Million | 128.8 Million | 555.44 Million | 186.54 Million | 166.72 Million |
| Earnings Per Share Basic | 0.61 | 0.43 | 0.32 | - | 0.46 | 0.41 |
| Earnings Per Share Diluted | 0.61 | 0.43 | 0.32 | - | 0.46 | 0.41 |
| Weighted Average Shares Outstanding | 406.8 Million | 406.8 Million | 402.52 Million | 406.8 Million | 406.8 Million | 406.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 406.8 Million | 406.8 Million | 402.52 Million | 406.8 Million | 406.8 Million | 406.8 Million |
| Gross Margin | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.95 |
| EBIT Margin | 0.37 | 0.36 | 0.29 | - | 0.32 | 0.36 |
| Profit Margin | 0.33 | 0.27 | 0.24 | 0.26 | 0.29 | 0.30 |
| EBITDA | 280.28 Million | 228.48 Million | 157.3 Million | - | 203.23 Million | 199.8 Million |
| Earnings Before Tax Margin | 0.38 | 0.32 | 0.31 | 0.32 | -1.22 | 0.38 |
002240
8613
MANTA
PFIE
CBGH
002678